Landec Corporation – NASDAQ:LNDC
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 15 hours
Landec stock price monthly change
-100.00%
month
Landec stock price quarterly change
-100.00%
quarter
Landec stock price yearly change
-100.00%
year
Landec key metrics
Market Cap | 263.62M |
Enterprise value | 411.90M |
P/E | -4.03 |
EV/Sales | 1.50 |
EV/EBITDA | -5.84 |
Price/Sales | 0.94 |
Price/Book | 2.67 |
PEG ratio | 0.02 |
EPS | -3.26 |
Revenue | 279.41M |
EBITDA | -76.83M |
Income | -96.63M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -36.56% |
Oper. margin | -32.13% |
Gross margin | 16.1% |
EBIT margin | -32.13% |
EBITDA margin | -27.5% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeLandec stock price history
Landec stock forecast
Landec financial statements
| Nov 2021 | 129.49M | -38.44M | -29.69% |
|---|---|---|---|
| Feb 2022 | 53.07M | -7.10M | -13.39% |
| May 2022 | 47.62M | -35.76M | -75.09% |
| Feb 2023 | 49.22M | -15.32M | -31.13% |
| 2022-08-10 | -0.01 | -0.01 |
|---|---|---|
| 2022-10-06 | -0.13 | -0.32 |
| May 2022 | 295160000 | 187.21M | 63.43% |
|---|---|---|---|
| Aug 2022 | 285800000 | 188.90M | 66.1% |
| Nov 2022 | 279073000 | 204.90M | 73.42% |
| Feb 2023 | 236153000 | 163.43M | 69.21% |
| Nov 2021 | -5.13M | -5.09M | 9.87M |
|---|---|---|---|
| Feb 2022 | -20.12M | 67.98M | -47.09M |
| May 2022 | 36K | -19.38M | 19.14M |
| Feb 2023 | -15.46M | 0 | 0 |
Landec alternative data
| Aug 2023 | 689 |
|---|---|
| Sep 2023 | 689 |
| Oct 2023 | 689 |
| Nov 2023 | 689 |
| Dec 2023 | 689 |
| Jan 2024 | 689 |
| Feb 2024 | 689 |
| Mar 2024 | 689 |
| Apr 2024 | 689 |
| May 2024 | 689 |
| Jun 2024 | 689 |
| Jul 2024 | 689 |
Landec other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jan 2022 | 397400 | 0 |
| Oct 2022 | 250000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10 percent owner | Common Stock, $0.001 par value per share | 103,000 | $8.09 | $833,270 | ||
Purchase | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10 percent owner | Common Stock, $0.001 par value per share | 147,000 | $8.09 | $1,189,230 | ||
Option | HALL JAMES G officer: Vice Pre.. | Restricted Stock Unit | 10,000 | $10.42 | $104,200 | ||
Option | POWELL ANDREW KENNETH WILLIAM director | Restricted Stock Unit | 7,059 | $9.5 | $67,061 | ||
Option | OBUS NELSON director | Restricted Stock Unit | 7,059 | $9.5 | $67,061 | ||
Option | HOUDE LOVAS KATRINA director | Restricted Stock Unit | 7,059 | $9.5 | $67,061 | ||
Option | PANKOPF TONIA L director | Restricted Stock Unit | 7,059 | $9.5 | $67,061 | ||
Option | SOHN CATHERINE A. director | Restricted Stock Unit | 7,059 | $9.5 | $67,061 | ||
Option | EDWARDS JEFFREY L director | Restricted Stock Unit | 7,059 | $9.5 | $67,061 | ||
Option | CAROSELLA DEBORAH D director | Restricted Stock Unit | 7,059 | $9.5 | $67,061 |
| Quarter | Transcript |
|---|---|
| Q1 2023 6 Oct 2022 | Q1 2023 Earnings Call Transcript |
| Q4 2022 10 Aug 2022 | Q4 2022 Earnings Call Transcript |
| Q3 2022 5 Apr 2022 | Q3 2022 Earnings Call Transcript |
| Q2 2022 5 Jan 2022 | Q2 2022 Earnings Call Transcript |
-
When is Landec's next earnings date?
Unfortunately, Landec's (LNDC) next earnings date is currently unknown.
-
Does Landec pay dividends?
No, Landec does not pay dividends.
-
How much money does Landec make?
Landec has a market capitalization of 263.62M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 65.86% to 185.79M US dollars. Landec made a loss 46.28M US dollars in net income (profit) last year or -$0.32 on an earnings per share basis.
-
What is Landec's stock symbol?
Landec Corporation is traded on the NASDAQ under the ticker symbol "LNDC".
-
What is Landec's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Landec?
Shares of Landec can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Landec's key executives?
Landec's management team includes the following people:
- Dr. Albert D. Bolles Ph.D. Chief Executive Officer, Pres & Director(age: 67, pay: $989,460)
- Mr. James G. Hall Vice President & Pres of Lifecore(age: 62, pay: $706,260)
- Mr. John D. Morberg Chief Financial Officer & Sec.(age: 61, pay: $472,370)
- Mr. Timothy P. Burgess Senior Vice President of Supply Chain - Curation Foods(age: 62, pay: $439,450)
-
How many employees does Landec have?
As Jul 2024, Landec employs 689 workers.
-
When Landec went public?
Landec Corporation is publicly traded company for more then 29 years since IPO on 16 Feb 1996.
-
What is Landec's official website?
The official website for Landec is landec.com.
-
Where are Landec's headquarters?
Landec is headquartered at 5201 Great America Pkwy Ste 232, Santa Clara, CALIFORNIA.
-
How can i contact Landec?
Landec's mailing address is 5201 Great America Pkwy Ste 232, Santa Clara, CALIFORNIA and company can be reached via phone at +1 650 306 1650.
Landec company profile:
Landec Corporation
landec.comExchange:
NASDAQ
Full time employees:
689
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. Landec Corporation was incorporated in 1986 and is headquartered in Santa Maria, California.
5201 Great America Pkwy Ste 232
Santa Clara, CALIFORNIA 93455
Santa Clara, CALIFORNIA 93455
CIK: 0001005286
ISIN: US5147661046
CUSIP: 514766104
